Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
105 Cards in this Set
- Front
- Back
LCX (left circumflex) supplies:
|
L and posterior walls of LV
|
|
LAD supplies:
(3) |
1. ant. 2/3 of IV septum
2. ant. papillary muscle 3. ant. surface of LV |
|
PDA (off RCA) supplies:
(2) |
1. post. 1/3 of IV septum
2. post. walls of BOTH ventricles |
|
acute marginal artery (off of RCA) supplies:
(1) |
RV
|
|
the SA and AV nodes are usually supplied by:
|
RCA
|
|
coronary artery occlusion most commonly occurs in the:
|
LAD
- then RCA, then LCX |
|
when does coronary blood flow peak?
|
in early diastole
|
|
the most posterior part of the heart is the:
|
LA
- enlargement can cause dysphagia (compresses esophagus) or hoarseness (~recurrent laryngeal nerve off of vagus) |
|
MAP =
(equation) |
CO x TPR = 2/3 DP + 1/3 SP
|
|
Pulse Pressure =
|
SP - DP
|
|
PP is increased in:
(4) |
1. hypertrophy
2. aortic regurg 3. ob. SA 4. exercise (transient) |
|
PP is decreased in:
(4) |
1. aortic stenosis
2. cardiogenic shock 3. cardiac tamponade 4. advanced HF |
|
during the late stage of exercise, CO is maintained by:
|
HR only
- SV plateaus |
|
when HR increases, diastole is:
|
preferentially shortened
=> less filling time => dec. CA check FA - CA? |
|
***SV increases with:***
(3) |
1. inc. contractility
2. inc. preload 3. DEC. AF |
|
SV also increases in:
(3) |
1. anxiety
2. exercise 3. preg. |
|
***contractility increases with:***
(4) |
1. cat's
(inc. Ca2+ pump at sarco retic.) 2. inc. Ca2+ 3. dec. extracellular Na+ (=> dec. activity of Na+/Ca2+ xch. => Ca2+ stays in the cytoplasm) 4. Digitalis (blocks Na+/K+ => inc. intracellular Na+ => Na/Ca xch. => inc. intracell. Ca2+) check - cross-reference with FA |
|
contractility decreases with:
(6) |
1. B1 block
(dec. cAMP) 2. HF with systolic dysfunction 3. acidosis 4. DCM 5. hypoxia/hypercapnea (dec. PO2/inc. PCO2) 6. non-dihydro Ca2+ chan blockers |
|
myocardial O2 demand is increased by:
(4) |
1. inc. AF
(proportional to arterial pressure) 2. inc. contractility 3. inc. HR 4. inc. ventricular diameter (=> inc. wall tension) |
|
preload = EDV; it decreases with:
|
decreased venous tone
- venodilators like nitroglycerin dec. venous tone |
|
AF ~~
|
MAP
|
|
ACEI's and ARB's dec. BOTH:
|
preload AND AF
(they dec. volume and prevent vasoconstriction) |
|
EF ~~ ventricular contractility; nl EF >=
|
55%
|
|
EF is ______________ in systolic HF, and __________ in diastolic HF
|
decreased in systolic HF,
NORMAL in diastolic HF |
|
viscosity depends mostly on:
|
hematocrit
|
|
viscosity is inc'd in:
(3) |
1. polycythemia
2. hyper-proteinemic states (e.g. MM) 3. non-hereditary spherocytosis |
|
viscosity is decreased in:
|
anemia
|
|
inotropy =
|
change in contractility that => change in CO
|
|
2 examples that cause positive inotropy:
|
1. cat's
2. Digoxin (inc. contractility => inc. CO) |
|
2 examples of neg. inotropy:
|
1. uncompensated HF
2. narcotic OD (=> dec. contractility => dec. CO) |
|
venous return ~~
(2) |
1. blood volume
2. TPR |
|
relationship of venous return to blood volume:
|
venous return proportional to blood volume
(also to sympathetic activity) |
|
relationship of venous return to TPR:
|
dec. TPR = inc. in venous return
dTPR ~~ change in SLOPE of venous return (x-intercept stays put if CO increases to offset dec. in TPR) - TPR and slope are INVERSELY proportional |
|
PR interval ~~
|
conduction b/w atria and ventricles
|
|
QT interval ~~
|
mechanical contraction of the ventricles
|
|
U wave:
(3) |
1. pathogenic
2. right after T wave 3. caused by hypoK+, bradycardia |
|
ranking of speed of conduction by area of the heart:
|
Purkinje > atria > ventricles > AV node
|
|
speed of conduction of Pacemakers:
|
SA > AV > bundle of His/Purkinje
|
|
features of Torsades:
(2) |
1. a ventricular tachy
2. can progress to V-fib |
|
a long QT interval predisposes to:
|
Torsades
|
|
causes of Torsades:
(3) |
1. QT-interval prolonging drugs
(see below) 2. dec. K+ 3. dec. Mg2+ |
|
Some Risky Meds Can Prolong QT:
|
Sotalol
Risperidone Macrolides Chloroquine Protease inhibitors (-navirs) Quinidine (class Ia, III) Thiazides |
|
congenital long QT syndrome =
|
disorder of myocardial repol
|
|
congenital long QT syndrome increases the risk of:
|
sudden cardiac death due to Torsades
|
|
2 kinds of congenital long QT syndrome:
|
1. Romano-Ward syndrome
2. Jervell and Lange-Nielsen syndrome |
|
2 features of Romano-Ward syndrome:
|
1. AD
2. pure cardiac phenotype (no deafness) |
|
2 features of Jervell and Lange-Nielsen syndrome:
|
1. AR
2. ~~ Torsades AND sensorineural deafness |
|
WPW syndrome =
|
m.c. ventricular pre-excitation syndrome
|
|
WPW pathophys:
|
electrical signal bypasses AV node via the abnly-fast bundle of Kent
=> ventricles begin to partially depol. earlier => shortened PR interval, characteristic delta wave |
|
WPW may result in:
|
REENTRY CIRCUIT
=> supra-V-tach |
|
features of a-fib:
(3) |
1. irregularly irregular
2. **NO discrete P waves** 3. irregularly-spaced QRS complexes |
|
a-fib => inc. risk for:
|
atrial stasis, => thromboembolic stroke
|
|
tx of a-fib =
(3) |
1. rate control
2. anticoags 3. cardioversion (reset to nl rhythm via electricity or drugs) |
|
features of atrial flutter:
(2) |
1. rapid succession of back-to-back atrial depol waves
2. => sawtooth appearance |
|
tx of a-flutter:
(3) |
1. catheter ablation (definitive)
2. conversion to sinus rhythm: class IA, IC, or III antiarrhythmics 3. rate control: B- or Ca2+ chan. blocker |
|
features of V-fib:
(2) |
1. **completely erratic** rhythm with **no identifiable waves**
2. fatal w/o immediate CPR and defib. |
|
3 features of 1st-degree AV block:
|
1. prolonged PR interval (>200 msec)
2. benign, asymp 3. NO tx nec. |
|
two 2nd-degree AV blocks:
|
1. Mobitz type I / Wenckenbach
2. Mobitz type II |
|
features of Mobitz type I / Wenckenbach:
(4) |
1. progressive lengthening of the PR interval...
2. ...until a beat (i.e. QRS) is dropped (P wave NOT followed by QRS 3. reset 4. usually asymp |
|
features of Mobitz type II:
(3) |
1. 2:1 pattern
(2 P waves followed by QRS) 2. NO lengthening of PR interval 3. may progress to 3rd-degree block |
|
tx of Mobitz type II =
|
pacemaker
|
|
features of 3rd-degree / complete AV block:
(3) |
1. atria and ventricles beat independently of each other
2. atrial rate is faster than the ventricular rate 3. pot.ly caused by Lyme dz |
|
tx of 3rd-degree AV block =
|
pacemaker
|
|
mechanism/effects of ANP:
(6) |
1. constricts efferent arterioles,
2. dilates afferent arterioles ==> Na+/H2O into urine (^via cGMP^) 3. inhibits Na+ reabsorption at collecting tubule 4. inhibits renin secretion 5. restricts aldo secretion at the adrenal glands 6. vasodilates => aldo escape |
|
3 features of BNP:
|
1. released from VENTRICULAR myocytes
2. in response to inc. tension of ventricles 3. longer half-life than ANP |
|
BNP blood test is used to dx:
|
HF
|
|
name of recombinant BNP drug:
|
Nesiritide,
for HF |
|
2 ways to stimulate carotid sinus firing:
|
1. inc. BP
2. carotid massage (mechanical pressing) |
|
3 effects of stimulating carotid sinus baro r's:
|
1. vasodilation
2. dec. HR/contractility 3. dec. BP |
|
aortic arch baro r's respond ONLY to:
|
inc. BP
- carotid baro r's respond to both inc. AND dec. in BP |
|
peripheral chemo r's are found in:
(2) |
carotid bodies,
aortic body |
|
**peripheral chemo r's are stimulated by:**
(3) |
dec. PO2 (<60)
inc. PCO2 dec. pH of blood |
|
central chemo r's are stimulated by:
|
changes in pH and PCO2 of interstitial fluid, which are influenced by **arterial PCO2**
- r's do NOT directly respond to PO2 changes |
|
***inc. O2 demand is met with:***
|
inc. coronary blood flow,
NOT inc. extraction of O2 (already extracting as much as it can) |
|
PDA ~~
|
left-to-right shunt
(where blood avoids arterioles and hits pulmonary circulation instead) - eventually, becomes R-to-L shunt, as right side has greater volume |
|
persistent truncus arteriosus =
|
failure of truncus arteriosus to divide into pulmonary trunk and aorta
- most pts have accompanying VSD |
|
D-transposition of the great vessels =
|
aorta leaving RV,
pulmonary trunk leaving LV (posterior) - not compatible with life unless a shunt is present to allow mixing of blood |
|
tricuspid atresia =
|
absence of tricuspid valve and hypoplastic RV; requires both ASD and VSD for viability.
|
|
Tetralogy of Fallot =
|
1. Pulmonary infundibular stenosis
(most imp. determinant of prognosis) 2. RVH (boot-shaped heart on CXR) 3. Overriding aorta (aorta right next to/right off of VSD, not LV) 4. VSD |
|
truncus arteriosus =
|
failure of truncus arteriosis to divide into pulmonary trunk and aorta
~~ VSD |
|
S1 =
|
MV and tricuspid valve closing
- loudest at mitral area |
|
S2 =
|
aortic and pulmonary valves closing
- loudest at left sternal border |
|
atheroma =
|
degeneration of walls of arteries, due to accumulation of fatty deposits and scar tissue
|
|
activated mP's of an atheroma secrete ___________________ to __________________________
|
metalloproteinases
to help degrade collagen |
|
what 2 separate features of a plaque make it liable to rupture?
(=> thrombosis, embolism) |
1. thin fibrous cap
2. rich lipid core |
|
endocardium is not only the innermost surface of the heart, but also forms:
|
the surface of the valves
|
|
m.c.c. of sudden cardiac death =
|
V-fib
|
|
S3:
(4) |
1. occurs immediately after S2, during diastole/ filling
2. ~~ LV systolic failure 3. ~~ blood coming into partially-filled ventricle (e.g. mitral regurg, CHF) 4. NL in children and preg. |
|
S3 is best heard at:
|
ventricular apex,
***esp. in lateral decubitis pos (lying down), and EXHALING completely*** (brings heart closer to chest wall) |
|
S4:
(3) |
1. late diastole
2. ~~ ventricular hypert 3. - HCM, HTN, Aortic Stenosis |
|
pathologies heard during systole:
(5) |
1. aortic stenosis
2. pulmonic stenosis 3. mitral regurg 4. tricuspid regurg 5. VSD |
|
pathologies heard during diastole:
(4) |
1. aortic regurg
2. pulmonic regurg 3. mitral stenosis 4. tricuspid stenosis |
|
jaw claudication =
|
pain while chewing
|
|
cardiac defects of 22q11:
(e.g. DiGeroge) (2) |
1. truncus arteriosus
2. Tetralogy of Fallot |
|
cardiac defects of Down syndrome:
(2) |
1. septal defects (ASD/VSD)
2. AV septal defect (endocardial cushion defect) |
|
cardiac defects of congenital rubella:
(3) |
1. septal defects
2. PDA 3. pulm. artery stenosis |
|
cardiac defects of Turner syndrome:
(2) |
1. bicuspid aortic valve
2. (pre-PDA) coarctation of aorta |
|
cardiac defects of Marfan:
(2) |
1. MVP
2. (thoracic) aortic aneurysm and dissection |
|
cardiac defect from diabetic mother:
|
transposition of great vessels
|
|
3 dihydropyridine Ca2+ chan. blockers:
|
1. Amlodipine
2. Nimodipine 3. Nifedipine |
|
2 NON-dihydro Ca2+ chan. blockers:
|
1. Diltiazem
2. Verapamil |
|
ACEI's/ARB's are protective against:
|
diabetic nephropathy
|
|
B-blockers must be used cautiously in decompensated CHF, and absolutely contraindicated in:
(2) |
cardiogenic shock,
suspected cocaine |
|
eccentric hypert:
(4) |
1. Volume overload
2. => inc. LV chamber size 3. => SYSTolic dysfunction 4. = contractile dysfunction |
|
concentric hypert:
(4) |
1. ~~ chronic Pressure overload
2. => dec. LV chamber size, 3. => dec. compliance (STIFF) 4. = DIASTOLIC dysfunction (can't fill as well) |